Literature DB >> 12574769

A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.

Neil Bhattacharyya1.   

Abstract

OBJECTIVE: The study purpose was to determine survival and prognostic factors for differentiated thyroid carcinoma (DTC).
METHODS: Cases of DTC were extracted from the Surveillance, Epidemiology and End Results database from 1988 through 1998. Kaplan-Meier survival analysis was conducted for papillary, follicular, and medullary histologies. Cox proportional hazard analysis was used to examine the influence of age, gender, tumor size, local extension, and cervical node involvement on overall survival.
RESULTS: A total of 18,118 cases were identified, including 15,820 (87.3%) papillary carcinomas, 1799 (9.9%) follicular carcinomas, and 499 (2.8%) medullary carcinomas. Mean survival (10-year survival) was 122 (87.7%), 117 (80.2%), and 108 (73.7%) months for papillary, follicular, and medullary tumors, respectively. For each histology, increasing age, male gender, and degree of local extension substantially reduced survival. Cervical metastasis did not influence survival for papillary or follicular carcinomas but approached significance for medullary carcinoma (P = 0.065).
CONCLUSIONS: Degree of local extension in thyroid carcinoma should be subclassified to more accurately determine prognosis. Treatment of the neck should be considered for medullary thyroid carcinoma.

Entities:  

Mesh:

Year:  2003        PMID: 12574769     DOI: 10.1067/mhn.2003.2

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  25 in total

1.  Adjuvant external beam radiation for medullary thyroid carcinoma.

Authors:  Steve R Martinez; Shannon H Beal; Allen Chen; Steven L Chen; Philip D Schneider
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

2.  Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.

Authors:  Matthew Truong; Mackenzie R Cook; Scott N Pinchot; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2010-12-24       Impact factor: 5.344

3.  Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma.

Authors:  Daniel Barretto Kendler; Mario Lucio Araújo; Renata Alencar; Maria Theresa de Souza Accioly; Daniel Alves Bulzico; Cencita Cordeiro de Noronha Pessoa; Fernanda Andrade Accioly; Terence Pires de Farias; Flaia Paiva Proença Lobo Lopes; Rossana Corbo; Mario Vaisman; Fernanda Vaisman
Journal:  Endocrine       Date:  2017-09-25       Impact factor: 3.633

Review 4.  Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications.

Authors:  Bin Xu; Ronald A Ghossein
Journal:  Histopathology       Date:  2018-01       Impact factor: 5.087

5.  Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.

Authors:  Mackenzie Cook; Xiao-Min Yu; Herbert Chen
Journal:  Am J Transl Res       Date:  2010-02-10       Impact factor: 4.060

6.  2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.

Authors:  R Elisei; M Alevizaki; B Conte-Devolx; K Frank-Raue; V Leite; G R Williams
Journal:  Eur Thyroid J       Date:  2012-12-19

7.  Medullary thyroid carcinoma: The third most common thyroid cancer reviewed.

Authors:  Michael Stamatakos; Panoraia Paraskeva; Charikleia Stefanaki; Paraskevas Katsaronis; Andreas Lazaris; Konstantinos Safioleas; Konstantinos Kontzoglou
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

8.  MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.

Authors:  Jocelyn F Burke; Logan Schlosser; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2013-07-31       Impact factor: 5.344

9.  Mortality-related factors in 1056 radioiodine-treated patients with well-differentiated thyroid cancer in southern Thailand.

Authors:  Tada Yipintsoi; Teerapon Premprabha; Alan Geater; Tanyaluck Thientunyakij; Suchitra Thongmak
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

10.  Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases.

Authors:  Lenine G Brandão; Beatriz G Cavalheiro; Consuelo R Junqueira
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.